stockrowGuardian Pharmacy Services, Inc.
GRDN Healthcare Medical Care Facilities
Guardian Pharmacy Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 17.9% from fiscal 2024.
- Revenue
- −1.68%
- EPS
- +133.3%
- Free cash flow
- +88.9%
Quarter to September 2026, against a year earlier
Follow GRDN
Alert me
Guardian Pharmacy Services, Inc. (GRDN) Free cash flow margin
Guardian Pharmacy Services, Inc.'s free cash flow margin over the twelve months to 30 September 2026 was 7.83%, up 2.3 percentage points from fiscal 2025 (5.57%). That is above the Medical Care Facilities industry median of 6.97% and above the Healthcare sector median of 0.00%.
Free cash flow margin, annual
Embed this chart
Annual newest first
| Period | Free cash flow margin | Change (points) |
|---|---|---|
| FY2025 | 5.57% | 2.18 |
| FY2024 | 3.39% | (1.99) |
| FY2023 | 5.38% | — |
Free cash flow margin against peers
| Company | Free cash flow margin |
|---|---|
| NHC National HealthCare Corporation compare | 14.0% |
| MD Pediatrix Medical Group, Inc. compare | 10.7% |
| ADUS Addus HomeCare Corporation compare | 9.61% |
| GRDN Guardian Pharmacy Services, Inc. | 7.83% |
| AVAH Aveanna Healthcare Holdings Inc. compare | 6.09% |
| SGRY Surgery Partners, Inc. compare | 5.69% |
| ASTH Astrana Health, Inc. compare | 2.46% |
| ACHC Acadia Healthcare Company, Inc. compare | 0.31% |
| BKD Brookdale Senior Living Inc. compare | −4.62% |
| Medical Care Facilities industry median | 6.97% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Free cash flow margin is
Free Cash Flow Margin tells an investor how much of each sale turns into cash the company keeps after paying for investment in its assets.
(Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)) ÷ Revenue